We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
+1.48%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$12.3B
AUM Growth
+$966M
Cap. Flow
+$867M
Cap. Flow %
7.08%
Top 10 Hldgs %
51.59%
Holding
825
New
217
Increased
182
Reduced
275
Closed
151

Sector Composition

Rank Sector Weight
1 Energy 66.36%
2 Materials 2.69%
3 Financials 2.67%
4 Healthcare 2.57%
5 Technology 1.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARE icon
226
Alexandria Real Estate Equities
ARE
$8.88B
$916K 0.01%
+8,423
New +$917K
GOOGL icon
227
Alphabet (Google) Class A
GOOGL
$3.91T
$899K 0.01%
22,360
-12,100
-35% -$473K
META icon
228
Meta Platforms (Facebook)
META
$1.51T
$894K 0.01%
6,973
+891
+15% +$111K
REG icon
229
Regency Centers
REG
$15B
$859K 0.01%
11,086
+83
+0.8% +$6.71K
AIMT
230
DELISTED
Aimmune Therapeutics
AIMT
$808K 0.01%
53,867
-5,484
-9% -$74K
PDLI
231
DELISTED
PDL BioPharma, Inc.
PDLI
$801K 0.01%
239,051
-129,043
-35% -$410K
MSFT icon
232
Microsoft
MSFT
$2.84T
$789K 0.01%
13,694
+5,339
+64% +$301K
ATRA icon
233
Atara Biotherapeutics
ATRA
$71.2M
$786K 0.01%
+1,469
New +$798K
ARDX icon
234
Ardelyx
ARDX
$1.24B
$779K 0.01%
+60,236
New +$631K
SNLN
235
DELISTED
Highland/iBoxx Senior Loan ETF
SNLN
$775K 0.01%
+41,578
New +$772K
VTAE
236
DELISTED
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
$769K 0.01%
36,767
-3,748
-9% -$43.2K
EPZM
237
DELISTED
Epizyme, Inc
EPZM
$727K 0.01%
73,886
-6,501
-8% -$59.3K
LOXO
238
DELISTED
Loxo Oncology, Inc
LOXO
$723K 0.01%
27,618
-2,397
-8% -$62.7K
ACC
239
DELISTED
American Campus Communities, Inc.
ACC
$719K 0.01%
+14,135
New +$725K
SCMP
240
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
$719K 0.01%
58,415
-41,786
-42% -$492K
SBUX icon
241
Starbucks
SBUX
$118B
$708K 0.01%
13,084
+9,230
+239% +$516K
OTIC
242
DELISTED
Otonomy, Inc.
OTIC
$700K 0.01%
38,460
-3,844
-9% -$62.8K
KRC icon
243
Kilroy Realty
KRC
$4.58B
$694K 0.01%
10,006
-480
-5% -$33.8K
FLXN
244
DELISTED
Flexion Therapeutics, Inc.
FLXN
$686K 0.01%
35,084
+4,783
+16% +$80.9K
GILD icon
245
Gilead Sciences
GILD
$161B
$644K 0.01%
8,145
+713
+10% +$57.9K
MCRB icon
246
Seres Therapeutics
MCRB
$48M
$631K 0.01%
2,567
-209
-8% -$73.3K
DIS icon
247
Walt Disney
DIS
$165B
$616K 0.01%
6,629
-754
-10% -$72.2K
PTCT icon
248
PTC Therapeutics
PTCT
$6.37B
$612K 0.01%
43,660
-4,475
-9% -$36.4K
WES icon
249
Western Midstream Partners
WES
$19.6B
$600K ﹤0.01%
14,119
+4,371
+45% +$165K
UPS icon
250
United Parcel Service
UPS
$97.6B
$597K ﹤0.01%
5,455
+380
+7% +$41.5K

Similar funds

ALPS Advisors's Q3 2016 Portfolio in Review

As of Q3 2016, ALPS Advisors held 825 positions worth $12.3B, up 8.6% from $11.3B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

ALPS Advisors deployed $867M of net new capital in Q3 2016, opening 217 new positions and adding to 182 existing holdings. Its largest new stake was Boardwalk Pipeline Partners: 7,906,111 shares worth $136M.

By sector, the portfolio is most concentrated in Energy at 66% of assets, down from 69% a quarter earlier, followed by Materials and Financials.

On the sell side, the largest reduction was Cheniere Energy, an estimated $77.7M trimmed.

  • ALPS Advisors's largest Q3 2016 buy was Boardwalk Pipeline Partners: 7,906,111 shares worth $136M.
  • ALPS Advisors added most to Enterprise Products Partners in Q3 2016, an estimated $114M increase.
  • ALPS Advisors's biggest Q3 2016 reduction was Cheniere Energy, cutting an estimated $77.7M.
  • ALPS Advisors fully exited Goldcorp Inc in Q3 2016, selling an estimated $33M.
  • ALPS Advisors's ten largest holdings make up 52% of its $12.3B portfolio in Q3 2016.
  • ALPS Advisors opened 217 new positions and closed 151 in Q3 2016.
  • ALPS Advisors's portfolio value rose 8.6% quarter-over-quarter to $12.3B.

Based on ALPS Advisors's 13F filing for Q3 2016, filed 2 Nov 2016.